I am a
Home I AM A Search Login

Papers of the Week


January 27, 2023


Dent J (Basel)


http://www.ncbi.nlm.nih.gov/pubmed/36661563?dopt=Abstract


11


1

Different Treatment Modalities of Oral Lichen Planus-A Narrative Review.

Authors

Andabak-Rogulj A, Vindiš E, Aleksijević L H, Škrinjar I, Juras D V, Aščić A, Brzak B L
Dent J (Basel). 2023 Jan 12; 11(1).
PMID: 36661563.

Abstract

Oral lichen planus (OLP) is a chronic inflammatory disease of unknown etiology which affects the oral mucosa. OLP varies in its clinical features from a reticular form that is, in most cases, asymptomatic, to atrophic-erosive, and is accompanied by symptoms of burning sensation and pain followed by difficulty in eating. Given the fact that OLP is a disease of unknown etiology, the treatment is symptomatic and involves suppressing the signs and symptoms of the disease using various topical and systemic drugs. The first line of therapy for treating symptomatic OLP is topical corticosteroids, whereas systemic corticosteroids are used for treating persistent lesions that do not respond to local treatment. However, the lack of convincing evidence on the efficacy of previous therapies, including topical corticosteroids, and numerous side effects that have appeared over recent years has resulted in the emergence and development of new therapeutic options. Some of the therapies mentioned are tacrolimus, efalizumab, dapson, interferon, retinoic acid, photochemotherapy with psoralen and ultraviolet A rays (PUVA), aloe vera, antimalarials, antibiotics and others. These therapies only partially meet the properties of efficacy and safety of use, thus justifying the continuous search and testing of new treatment methods.